Aspira Women's Health, Inc. (AWHL)
0.2378
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Aspira Women's Health Enterprise Value : 13.72M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 13.72M |
| October 01, 2026 | 13.58M |
| September 30, 2026 | 13.35M |
| September 29, 2026 | 13.36M |
| September 28, 2026 | 13.36M |
| September 25, 2026 | 14.56M |
| September 24, 2026 | 14.64M |
| September 23, 2026 | 14.75M |
| September 22, 2026 | 15.22M |
| September 21, 2026 | 15.22M |
| September 18, 2026 | 14.29M |
| September 17, 2026 | 15.91M |
| September 16, 2026 | 15.99M |
| September 15, 2026 | 16.15M |
| September 14, 2026 | 16.62M |
| September 11, 2026 | 16.66M |
| September 10, 2026 | 16.62M |
| September 09, 2026 | 15.22M |
| September 08, 2026 | 16.62M |
| September 04, 2026 | 16.62M |
| September 03, 2026 | 16.62M |
| September 02, 2026 | 15.62M |
| September 01, 2026 | 15.62M |
| August 31, 2026 | 15.62M |
| August 28, 2026 | 14.87M |
| Date | Value |
|---|---|
| August 27, 2026 | 14.87M |
| August 26, 2026 | 14.88M |
| August 25, 2026 | 15.22M |
| August 24, 2026 | 15.28M |
| August 21, 2026 | 14.83M |
| August 20, 2026 | 15.45M |
| August 19, 2026 | 17.55M |
| August 18, 2026 | 17.08M |
| August 17, 2026 | 18.48M |
| August 14, 2026 | 18.57M |
| August 13, 2026 | 18.95M |
| August 12, 2026 | 21.19M |
| August 11, 2026 | 21.19M |
| August 10, 2026 | 21.28M |
| August 07, 2026 | 20.35M |
| August 06, 2026 | 19.08M |
| August 05, 2026 | 19.41M |
| August 04, 2026 | 19.41M |
| August 03, 2026 | 18.95M |
| July 31, 2026 | 19.18M |
| July 30, 2026 | 17.91M |
| July 29, 2026 | 18.95M |
| July 28, 2026 | 21.19M |
| July 27, 2026 | 20.37M |
| July 24, 2026 | 20.37M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IDEXX Laboratories, Inc. | 41.79B |
| Neogen Corp. | 3.272B |
| QuidelOrtho Corp. | 3.688B |
| VolitionRX Ltd. | 10.08M |
| Lucid Diagnostics, Inc. | 111.17M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.42M |
| Revenue (Quarterly) | 2.046M |
| Total Expenses (Quarterly) | 4.466M |
| EPS Diluted (Quarterly) | -0.0547 |
| Gross Profit Margin (Quarterly) | 55.28% |
| Profit Margin (Quarterly) | -118.3% |
| Earnings Yield | -133.9% |
| Normalized Earnings Yield | -105.00 |